Xue Meng

机构：Weifang University · ORCID：0000-0001-7925-7295

发表论文 49 篇 · 总被引 335 次 · h-index 10

代表论文

• PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR) (2024 · Journal of Thoracic Oncology · 被引 17)
• The efficacy and safety of a novel PD‐1/CTLA‐4 bispecific antibody cadonilimab (AK104) in advanced non‐small cell lung cancer: A multicenter retrospective observational study (2024 · Thoracic Cancer · 被引 16)
• Addition of thoracic radiotherapy to a PD-L1 inhibitor plus chemotherapy regimen delays brain metastasis onset in extensive-stage small cell lung cancer patients without baseline brain metastasis (2025 · Respiratory Research · 被引 7)
• Non-small cell lung cancer associated with late-onset Lambert–Eaton myasthenic syndrome and paraneoplastic cerebellar degeneration (2019 · Neurological Sciences · 被引 7)
• 302P: Phase II study of the efficacy and safety of BNT327/PM8002 plus systemic chemotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC) (2025 · Journal of Thoracic Oncology · 被引 6)
• Promising early results of MHB088C (B7-H3 ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from a phase 1/2 multicenter study. (2025 · Journal of Clinical Oncology · 被引 4)